| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||
252,002 | 179,804 | 130,956 | 24,951 | - | - | - | - | - | - |
Total revenue | |||||||||
- | - | - | - | 2,782 | 1,742 | - | - | - | - |
Operating expenses: | |||||||||
Cost of sales | |||||||||
4,212 | 2,519 | 1,371 | - | - | - | - | - | - | - |
Selling, general and administrative | |||||||||
317,418 | 255,474 | 273,698 | 273,596 | 119,242 | 34,601 | 13,132 | 5,177 | 4,209 | 3,643 |
Research and development | |||||||||
242,799 | 207,301 | 191,499 | 153,893 | 112,696 | 80,311 | 27,942 | 16,182 | 11,426 | 12,709 |
Total operating expenses | |||||||||
564,429 | 465,294 | 466,568 | 427,489 | 231,938 | 114,912 | 41,073 | 21,359 | 15,635 | 16,353 |
Operating loss | |||||||||
-312,427 | -285,490 | -335,612 | -402,538 | -229,156 | -113,170 | - | - | - | - |
Other income (expense): | |||||||||
Revaluation of warrants | |||||||||
- | - | - | - | - | 170,832 | 28,441 | 24,625 | 1,044 | 672 |
Interest expense | |||||||||
41,144 | 30,523 | 29,271 | 14,196 | - | - | - | - | - | - |
Other income, net | |||||||||
8,890 | 6,771 | 4,516 | 3,904 | 2,727 | 776 | - | - | - | - |
Foreign currency loss on liquidation | |||||||||
- | - | - | - | - | - | - | -191 | - | 0 |
Other income, net | |||||||||
- | - | - | - | - | - | 100 | 87 | 47 | 104 |
QTDP Grant | |||||||||
- | - | - | - | - | - | - | - | - | 488 |
Total other (expense), net | |||||||||
-32,254 | -23,752 | -24,755 | -10,292 | 2,727 | -170,056 | -28,341 | -24,729 | 1,092 | 1,265 |
Net loss | |||||||||
-344,681 | -309,242 | -360,367 | -412,830 | -226,429 | -283,226 | -67,792 | -43,643 | -12,737 | -15,087 |
Net loss per common and potential common share: | |||||||||
Dividends on preferred stock, not declared | |||||||||
- | - | - | - | - | - | - | 2,630 | 3,000 | 2,901 |
Net loss attributable to common stockholders | |||||||||
- | - | - | - | - | - | -67,792 | -46,273 | -15,737 | -17,988 |
Basic and diluted | |||||||||
-10.89 | -10.86 | -14.38 | -16.74 | -9.56 | -13.63 | -3.76 | -7.36 | -4.73 | -5.40 |
Weighted average common and potential common shares outstanding: | |||||||||
Basic and diluted | |||||||||
31,654 | 28,464 | 25,054 | 24,663 | 23,694 | 20,784 | 18,028 | 6,283 | 3,329 | 3,329 |
Other comprehensive gain (loss): | |||||||||
Foreign currency translation adjustments | |||||||||
- | - | - | - | - | - | - | - | -6 | -100 |
Total comprehensive loss | |||||||||
- | - | - | - | - | - | - | - | -12,743 | -15,187 |
Product [Member] | |||||||||
Revenue | |||||||||
249,570 | 177,782 | 129,175 | 18,169 | - | - | - | - | - | - |
License [Member] | |||||||||
Revenue | |||||||||
2,432 | 2,022 | 1,781 | 6,782 | 2,782 | 1,742 | 1,622 | 2,446 | 1,805 | 0 |